Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in Blood Advances? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
BA
Blood Advances is a journal published by the American Society of Hematology featuring current issues, latest articles, collections, and author guidance in hematology.
Looking to publish in Blood Advances? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
Subject
Hematology
Impact Factor
7.1
Quartile
Q1
Open Access Type
Open
ISSN
2473-9529
eISSN
2473-9537
Invitation Only
No
Cost Range
Publication fees vary by article type.
Submission Instructions
Blood Advances accepts the following article types. Click on an article type to view submission instructions.
Regular Article
Cover Letter
A cover letter is required only to disclose any involvement of medical writers or researchers to the Editor-in-Chief. The cover letter must disclose any involvement of medical writers or researchers in writing the article.
Abstract
An abstract is required. The abstract must not exceed 250 words. The abstract must be unstructured and written as a continuous narrative.
Manuscript
Main text must not exceed 4,000 words, counting only the Introduction, Methods, Results, and Discussion. The manuscript should be ordered as Abstract, Key Points, Introduction, Methods, Results, Discussion, Acknowledgements, Authorship Contributions, Disclosure of Conflicts of Interest, References, Tables, Figure Legends, Figures, and Visual Abstract. The manuscript must include 1 to 2 Key Points of no more than 140 characters each, a Visual Abstract, and a subsection titled “Data Sharing Statement” on the title page that explains database access and provides a contact person for nonpublic data.
References
Regular Articles are recommended to include no more than 100 references. References must follow AMA guidelines when no specific style guidance is provided and be formatted according to the Blood Advances Style Guide. References must be listed in numerical order at the end of the article according to first citation in the text, with text citations given as superscript numbers.
Figures & Tables
Regular Articles are limited to 7 figures. Figures, tables, figure legends, and the Visual Abstract should appear after the references in the manuscript order, and supplemental data must be submitted with the original manuscript for peer review. The Visual Abstract must be submitted with the initial submission as a PPT file and must be clear, concise, original, minimally text-based, non-tabular, and free of trade names, logos, or trademarked images.
Review Article
Cover Letter
Cover Letter requirements are not specified.
Abstract
Review Articles must include an abstract. Abstract must not exceed 250 words. Abstract must be unstructured and written as a continuous narrative.
Manuscript
Review Articles must not exceed 4,000 words. Manuscript must be organized as Title Page, Key Points, Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, Authorship Contributions, Conflict of Interest Disclosures, References, Tables, Figure Legends, and Figures. Manuscript must include Key Points and sections for Acknowledgments, Authorship Contributions, and Conflict of Interest Disclosures.
References
Review Articles are recommended to include no more than 100 references. References must follow AMA style and the Blood Advances Style Guide. References must be numbered in the order cited, listed in numerical order at the end of the article, and cited in the text with superscript numbers.
Figures & Tables
Review Articles are limited to 7 figures. Sequences must be presented as figures rather than tables.
Systematic Review
Cover Letter
A cover letter is required if medical writers or researchers were involved in writing the Systematic Review. The cover letter must disclose any involvement of medical writers or researchers in writing the Systematic Review to the Editor-in-Chief.
Abstract
An abstract is required for Systematic Reviews. The abstract must not exceed 250 words. The abstract must be written as a continuous narrative and must not be broken into subheadings.
Manuscript
Main text must not exceed 4,000 words, counting only the Introduction, Methods, Results, and Discussion. The manuscript must be organized as Title Page, Key Points, Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, Authorship Contributions, Conflict of Interest Disclosures, References, Tables, Figure Legends, and Figures. Any involvement of medical writers or researchers in writing the Systematic Review must be clearly defined and disclosed in the Authorship and/or Acknowledgments section, and a data sharing statement must be included.
References
References must follow AMA guidelines when no specific style guidance is provided and be formatted according to the Blood Advances Style Guide. References must be listed in numerical order at the end of the article according to order of citation in the text, with citations shown as superscript numbers.
Figures & Tables
Systematic Reviews are limited to 7 figures. Sequences must be prepared as figures rather than tables.
Research Letter
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract is not required because Research Letters have no abstract.
Manuscript
Research Letters must not exceed 1,200 words of text. Research Letters must include a data sharing statement, and a Visual Abstract may be included with the submission.
References
Research Letters may include no more than 25 references. References must follow AMA guidelines unless specific style guidance is provided, and they must be formatted according to the Blood Advances Style Guide. References must be listed in numerical order at the end of the article according to order of citation, with superscript numbers used for in-text citations.
Figures & Tables
Research Letters may include up to 2 figures or tables.
Clinical Guidelines
Cover Letter
Cover Letter requirements are not specified.
Abstract
Clinical Guidelines must include an abstract. Abstract must not exceed 250 words. Abstract must be written as an unstructured continuous narrative.
Manuscript
Clinical Guidelines have no main text word limit. Manuscript must be organized as Title Page, Key Points, Abstract, Introduction, Methods, Results, Discussion, Acknowledgments, Authorship Contributions, Conflict of Interest Disclosures, References, Tables, Figure Legends, and Figures. Clinical Guidelines must include recommendations based on a high level of evidence and be relevant to patient care, and a Visual Abstract may be included.
References
References must follow AMA guidelines when no specific style guidance is provided. References must be listed in numerical order according to first citation in the text, with superscript citation numbers in the manuscript.
Figures & Tables
Clinical Guidelines have no figure limit.
Letter To The Editor
Cover Letter
Cover Letter requirements are not specified.
Abstract
Abstract is not required because Letters To The Editor have no abstract.
Manuscript
Manuscript text must not exceed 300 words, excluding the title, references, and author signatures. Letter title must be no more than 60 characters including spaces.
References
References must follow AMA guidelines and the Blood Advances Style Guide. References must be listed in numerical order by order of citation and cited in the text with superscript numbers.
Figures & Tables
Submission may include up to 1 figure or table.
Recent Publications
The roots run deep in therapy-related myeloid neoplasms
Maria Creignou, Elsa Bernard
10.1182/bloodadvances.2026021682
View Publication
CC-486 plus venetoclax: another step toward oral AML therapy
Kimberly Seymour, Marina Konopleva
10.1182/bloodadvances.2026021747
View Publication
Yu H, Schroeder JA, Mattson JG, Gao C, and Shi Q. Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice. Blood Adv. 2026;10(6):1883-1896.
-
10.1182/bloodadvances.2026022295
View Publication
Democratizing cancer risk testing in children before alloHCT
Lucy A. Godley, Timothy S. Olson
10.1182/bloodadvances.2026021568
View Publication
New views on VUSs in RUNX1-FPD
Akiko Shimamura, Alan B. Cantor
10.1182/bloodadvances.2026021243
View Publication
Frequently asked questions
How long does it take to publish?
Continuously published; new articles are added daily.
Reformat to Blood Advances using Livewrite PremiumIs a cover letter required?
Cover letter disclosures are required for certain article types when medical writers, researchers, or pharmaceutical or medical device company involvement applies. Advances Viewpoint and unsolicited Review Article submissions are expected to involve presubmission inquiry or prior contact with the Editor-in-Chief.
Reformat to Blood Advances using Livewrite PremiumWhat are the publication costs?
Publication fees apply and vary by article type.
Reformat to Blood Advances using Livewrite PremiumResearch Topics
Acute Myeloid Leukemia Research
Lymphoma Diagnosis and Treatment
CAR-T cell therapy research
Hematopoietic Stem Cell Transplantation
Chronic Lymphocytic Leukemia Research
Platelet Disorders and Treatments
Acute Lymphoblastic Leukemia research
Hemoglobinopathies and Related Disorders
Immune Cell Function and Interaction
Myeloproliferative Neoplasms: Diagnosis and Treatment
Multiple Myeloma Research and Treatments
Chronic Myeloid Leukemia Treatments
Blood groups and transfusion
Venous Thromboembolism Diagnosis and Management
Viral-associated cancers and disorders
Blood Coagulation and Thrombosis Mechanisms
Iron Metabolism and Disorders
T-cell and B-cell Immunology
Erythrocyte Function and Pathophysiology
Immunodeficiency and Autoimmune Disorders
Protein Degradation and Inhibitors
CNS Lymphoma Diagnosis and Treatment
Hemophilia Treatment and Research
Complement system in diseases
Virus-based gene therapy research